ABUS
Arbutus Biopharma Corp (ABUS) Investor Questions
Review Arbutus Biopharma Corp (ABUS) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- Arbutus Biopharma Corp
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 59
- Annual revenue
- $14.08M
- Annual net income
- $-33.50M
- Annual free cash flow
- $-39.64M
Arbutus Biopharma Corp (ABUS) Investor Questions research
Arbutus Biopharma Corp trades under the ticker ABUS. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review ABUS through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.